StephenACullinanMD

Oncology • Peoria, IL

Hematologic Oncology

Physician

Join to view full profile

Are you Dr. Cullinan?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 34 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
8940 N Wood Sage Rd
Peoria, IL 61615
Phone(309) 243-3000
Fax(309) 243-3050
Is this information wrong?

Summary

Dr. Stephen Cullinan, MD is an oncologist in Peoria, Illinois. He is currently licensed to practice medicine in Illinois, Tennessee, and Oklahoma. He is affiliated with UnityPoint Health - Peoria.

Education & Training

Mayo School of Graduate Medical EducationFellowship, Medical Oncology, 1975 - 1977
Henry Ford Hospital - Wayne State UniversityResidency, Internal Medicine, 1972 - 1974
University of Illinois College of MedicineClass of 1972

Certifications & Licensure

TN State Medical License 2008 - 2012
OK State Medical License 2006 - 2012
IN State Medical License 2001 - 2013
IL State Medical License Active through 2014
MO State Medical License Active through 2013
CO State Medical License Active through 2013
MI State Medical License Active through 2013
KY State Medical License Active through 2013
OH State Medical License Active through 2013
GA State Medical License Active through 2013
IA State Medical License Active through 2014
WI State Medical License Active through 2013
Join now to see all

Publications & Presentations

PubMed

Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)
Stuart M. Lichtman, Donna Hollis, Antonius A. Miller, Gary L. Rosner, Chris A. Rhoades, Eric P. Lester, Frederick Millard, John C. Byrd, Stephen A. Cullinan, D. Marc R...> ;Journal of Clinical Oncology. 2006 Apr 20
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.
Ingle JN, Twito DI, Schaid DJ, Cullinan SA, Krook JE, Mailliard JA, Tschetter LK, Long HJ, Gerstner JG, Windschitl HE> ;Cancer. 1991-02-15
A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
Cullinan S, Moertel CG, Wieand HS, Schutt AJ, Krook JE, Foley JF, Norris BD, Kardinal CG, Tschetter LK, Barlow JF> ;Cancer. 1990-05-15
Alternating chemotherapy with or without VP-16 in extensive-stage small-cell lung cancer.
Everson LK, Jett JR, O'Fallon JR, Krook JE, Dalton RJ, Mailliard JA, Tschetter LK, Cullinan SA, Gerstner JB, Morton RF> ;Am. J. Clin. Oncol.. 1989-08-01
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer.
Marschke RF, Ingle JN, Schaid DJ, Krook JE, Mailliard JA, Cullinan SA, Pfeifle DM, Votava HJ, Ebbert LP, Windschitl HE> ;Cancer. 1989-05-15
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breas...
James N. Ingle, L K Everson, H. Sam Wieand, Stephen A. Cullinan, Lester E. Wold, Jeffrey B. Hagen, J. Kirk Martin, James E. Krook, Robert G. Fitzgibbons, John F. Foley...> ;Cancer. 1989 Apr 1
Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer.
Buckner JC, Ingle JN, Everson LK, O'Fallon JR, Cullinan SA, Ahmann DL, Krook JE, Pfeifle DM> ;Breast Cancer Res. Treat.. 1989-03-01
Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinoma.
Marschke RF, Kvols LK, Cullinan SA, Laurie JA, Mailliard JA, Tschetter LK, O'Connell MJ> ;Med. Pediatr. Oncol.. 1988-01-01
Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatment.
Edmonson JH, Krook JE, Hilton JF, Long HJ, Cullinan SA, Everson LK, Malkasian GD> ;Cancer Treat Rep. 1986-08-01
Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage ...
Edmonson JH, McCormack GW, Fleming TR, Cullinan SA, Krook JE, Malkasian GD, Podratz KC, Mailliard JA, Jefferies JA, Barlow JF> ;Cancer Treat Rep. 1985-11-01
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorour...
Cullinan SA, Moertel CG, Fleming TR, Rubin JR, Krook JE, Everson LK, Windschitl HE, Twito DI, Marschke RF, Foley JF> ;JAMA. 1985-04-12
Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.
Krook JE, Ingle JN, Green SJ, Bowman WD, Everson LK, Windschitl HE, Marschke RF, Laurie JA, Cullinan SA, Pfeifle DM> ;Cancer Treat Rep. 1985-04-01
Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
Krook JE, Fleming TR, Eagan RT, Cullinan S, Pfeifle D, Elliott T, Etzell P> ;Cancer Treat Rep. 1984-03-01
Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
Windschitl HE, Krook JE, Everson LK, Cullinan SA, Scott M> ;Cancer Treat Rep. 1982-12-01
Phase II study of cytosine arabinoside in advanced large bowel cancer.
Cullinan SA, O'Connell MJ, Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ, Frytak S, Rubin J> ;Cancer Treat Rep. 1977-12-01
1 citation
Acute pulmonary hypersensitivity to carbamazepine.
Cullinan, S. A., Bower, G. C.> ;Chest. 1975 Oct 1
Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and ...
O'Connell, M. J., Klaassen, D. J., Everson, L. K., Cullinan, S., Wieand, H. S.> ;NCI Monogr. 1987
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
Ingle, J. N., Twito, D. I., Schaid, D. J., Cullinan, S. A., Krook, J. E., Mailliard, J. A., Marschke, R. F., Long, H. J., Gerstner, J. G., Windschitl, H. E.> ;J Clin Oncol. 1988 May
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausa...
Ingle, J. N., Everson, L. K., Wieand, H. S., Martin, J. K., Votava, H. J., Wold, L. E., Krook, J. E., Cullinan, S. A., Paulsen, J. K., Twito, D. I.> ;J Clin Oncol. 1988 Sep
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
Buroker, T. R., Moertel, C. G., Fleming, T. R., Everson, L. K., Cullinan, S. A., Krook, J. E., Mailliard, J. A., Marschke, R. F., Klaassen, D. J., Laurie, J. A.> ;J Clin Oncol. 1985 Dec
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
Poon, M. A., O'Connell, M. J., Moertel, C. G., Wieand, H. S., Cullinan, S. A., Everson, L. K., Krook, J. E., Mailliard, J. A., Laurie, J. A., Tschetter, L. K.> ;J Clin Oncol. 1989 Oct
FAM therapy for advanced gastric cancer: an ideal standard?
Cullinan, S. A., Moertel, C. G.> ;J Clin Oncol. 1985 Jun 01
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
Krook, J. E., Jett, J. R., Fleming, T. R., Dalton, R. J., Marschke, R. F., Cullinan, S. A., Windschitl, H. E., Everson, L. K., Brunk, F. S., Laurie, J. A.> ;J Clin Oncol. 1985 Jun 01
Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.
Morton, R. F., Creagan, E. T., Cullinan, S. A., Mailliard, J. A., Ebbert, L., Veeder, M. H., Chang, M.> ;J Clin Oncol. 1987 Jul
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.
Cullinan, S. A., Moertel, C. G., Wieand, H. S., O'Connell, M. J., Poon, M. A., Krook, J. E., Mailliard, J. A., Tschetter, L. K.> ;J Clin Oncol. 1994 Feb
Join now to see all

Hospital Affiliations

UnityPoint Health - PeoriaPeoria, Illinois